Symptomatik

Anxiety self-assessment

Free GAD-2 Ultra-Brief Anxiety Screen

Answer 2 short questions about the past two weeks. The GAD-2 is the ultra-brief screen made up of the first two items of the GAD-7, validated by Kroenke and colleagues in 2007 as a one-minute triage step for primary-care and EHR-embedded workflows. Your answers stay in this browser unless you choose to print, save, or share. Results show your 0–6 GAD-2 score with the validated ≥3 positive-screen cutoff and a direct path to the full GAD-7 if the screen is positive.

Frequently asked questions

What is the GAD-2?

The GAD-2 is a 2-item ultra-brief self-report screen for generalized anxiety disorder, made up of the first two items of the GAD-7. It was developed by Kroenke, Spitzer, Williams, Monahan, and Löwe and published in the Annals of Internal Medicine in 2007 as a one-minute primary-care triage step. Each item is rated 0 to 3 on the standard PHQ/GAD frequency Likert (Not at all / Several days / More than half the days / Nearly every day) and the two items are summed for a total between 0 and 6. The Kroenke 2007 positive-screen cutoff is ≥3, validated subsequently in Plummer and colleagues' 2016 systematic review and meta-analysis.

How is the GAD-2 scored, and what does the cutoff mean?

Each of the 2 items is rated 0 (Not at all) to 3 (Nearly every day). The total ranges from 0 to 6. A score of 3 or higher is a positive screen and the validated trigger to administer the full 7-item GAD-7 next; a score below 3 is a negative screen. The Kroenke 2007 cutoff of ≥3 was validated against clinician diagnosis of generalized anxiety disorder; Plummer and colleagues' 2016 meta-analysis pooled studies across primary-care and specialty settings and reported about 0.76 sensitivity and 0.81 specificity at that cutoff for generalized anxiety disorder. The 0–6 scale is too compressed to support a severity stratification, which is part of why the GAD-7 (0–21 with four severity bands) is the confirmatory step rather than a longer cutoff conversation on the GAD-2 itself.

Is the GAD-2 a diagnosis of anxiety?

No. The GAD-2 is a screening instrument, not a diagnostic test. A positive screen (≥3) is a signal to administer the longer GAD-7 — and to consider a clinical conversation — not a confirmed diagnosis of generalized anxiety disorder. Only a clinician can establish a clinical diagnosis, typically through a structured history that may also rule out panic disorder, social anxiety disorder, specific phobias, PTSD, OCD, and medical contributors that the ultra-brief screen does not differentiate among.

Is my data saved or shared?

Your answers stay in your browser. Symptomatik does not send your responses to any server. If you choose Print or PDF, that file is generated locally on your device.

About this screening tool

The GAD-2 was developed by Kurt Kroenke, Robert Spitzer, Janet Williams, Patrick Monahan, and Bernd Löwe and first published in the Annals of Internal Medicine in 2007 as part of a primary-care anxiety-disorders prevalence study. The two items it contains are the first two items of the GAD-7 (Spitzer 2006), chosen because they capture the highest-yield features of generalized anxiety for case-finding: persistent apprehension and uncontrollable worry. The instrument is in the public domain and is presented here verbatim. The Plummer 2016 systematic review and meta-analysis pooled data from multiple primary-care studies and confirmed the ≥3 cutoff's diagnostic accuracy for generalized anxiety disorder (pooled sensitivity 0.76, specificity 0.81), with somewhat lower performance against narrower anxiety diagnoses (social anxiety disorder, panic disorder, PTSD). The GAD-2 is used widely in primary care, electronic-health-record screening workflows, occupational health, integrated care for chronic medical conditions, and clinical research where a longer instrument is not feasible. Symptomatik presents the GAD-2 verbatim with the canonical 0–3 frequency Likert; the 2-band negative/positive split sits directly at the Kroenke 2007 cutoff. Plummer 2016 did not establish a minimum clinically important difference (MCID) for the GAD-2, and no formal MCID is in the published literature for the ultra-brief screen, which is part of why the GAD-7 is the right instrument for tracking change over time — the GAD-2 is a triage step, not a tracker.

References

  1. Kroenke K, Spitzer RL, Williams JB, Monahan PO, Löwe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317-325.
  2. Plummer F, Manea L, Trepel D, McMillan D. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. 2016;39:24-31.

Your GAD-2 score in context

The GAD-2 is a snapshot of the past two weeks, not a fixed measurement of your anxiety capacity or identity. Anxiety symptoms are highly responsive to circumstance — a looming deadline, a health concern, a relationship rupture, a financial pressure, a caregiving stretch, a new medication, a shift in sleep or substance use can all push the score meaningfully upward during the window you happened to take the screen. A genuinely settled fortnight can pull it downward. The two-week recall window the GAD-2 uses was inherited from the GAD-7 and was chosen to balance two competing needs: long enough to smooth out a single difficult day, short enough to detect change before a difficult pattern becomes entrenched.

One distinction worth pinning down: the GAD-2 is an ultra-brief triage step, not a severity instrument. Its 0–6 range is too compressed to support the severity bands a clinician will want to talk about (minimal / mild / moderate / severe); that is what the GAD-7 provides on its 0–21 scale. Reading a 4 or a 5 on the GAD-2 as if it told you the severity of your anxiety is a category error — the only thing the GAD-2 is calibrated to tell you is whether the longer GAD-7 (or a clinical conversation) is the appropriate next step. A score of 3 says yes; a score of 6 says yes the same way. The GAD-7 is where severity stratification happens.

On the positive-screen cutoff: a total of 3 or higher is the Kroenke 2007 validated threshold. Plummer and colleagues' 2016 meta-analysis pooled diagnostic-accuracy studies across multiple primary-care and specialty samples and confirmed the cutoff with a pooled sensitivity of about 0.76 and specificity of about 0.81 for generalized anxiety disorder. The GAD-2's specificity for narrower anxiety diagnoses (panic disorder, social anxiety disorder, PTSD) is lower than for generalized anxiety — the screen was not built to discriminate among anxiety subtypes, which is another reason a clinical conversation typically follows a positive ultra-brief screen rather than a categorical interpretation built off the GAD-2 alone.

When you retake the GAD-2, the change is less informative than a change on the GAD-7. No formal minimum clinically important difference (MCID) has been established for the GAD-2 — Plummer 2016 did not set one and one is not in subsequent literature — which is part of why the GAD-7 (with its established 4-point MCID) is the right instrument for serial measurement. If you want to track whether anxiety is settling, holding, or growing, the GAD-7 is the better tool; the GAD-2 is best thought of as a one-shot triage step at the moment you are deciding whether to invest in the longer screen or a clinical conversation.

How to bring this to a clinician

Most primary-care and mental-health clinicians recognize the GAD-2 on sight — it is the ultra-brief screen most commonly embedded in electronic-health-record workflows, occupational-health programs, and integrated primary-care models. You will not need to explain the instrument. That said, the right thing to bring to the conversation is usually not the GAD-2 score in isolation; it is the GAD-2 score plus a completed GAD-7. The full GAD-7 gives the clinician a 0–21 number with severity bands they already use for treatment decisions; the GAD-2 by itself, with its 0–6 range, does not support those decisions.

What to bring:

  • The GAD-2 total (on the 0–6 scale) and a quick note that it was a positive ultra-brief screen at ≥3
  • The full GAD-7 result if you took it (the total on the 0–21 scale, plus the items rated 2 or 3) — clinicians read the GAD-7 item pattern, not just the total, and the additional items the GAD-7 covers (trouble relaxing, restlessness, irritability, fearful anticipation, worry about different things) are clinically informative
  • How long the anxiety at this level has been present (best guess in weeks or months) — the duration matters for distinguishing acute reactive anxiety from a more sustained pattern
  • What has been happening in your life in the same window — a job change, a health concern, a relationship rupture, a caregiving stretch, a financial pressure, a medication change, a shift in caffeine or alcohol or sleep — that may be contributing
  • Whether panic episodes have occurred — sudden surges of intense physical fear, racing heart, breathing difficulty, dizziness — and if so, how often and whether they are escalating; panic is a different anxiety profile and may need distinct treatment planning
  • Whether avoidance has appeared or grown — situations or interactions you are stepping away from because the anticipatory anxiety is too costly
  • Whether sleep, mood, or perceived-stress symptoms are also part of the picture. If yes, bringing a PHQ-9 (depression), AIS (sleep), or PSS-10 (perceived stress) result to the same conversation usually shortens the path to a useful plan, because comorbidity is common at moderate or severe GAD-7 bands

A two-line opening you can use as-is:

I took the GAD-2 at home and scored [X] on the 0–6 scale, which is a positive ultra-brief screen at the ≥3 cutoff. I [did/did not] also complete the full GAD-7 — [if yes: scored Y on the 0–21 scale; the items that bothered me most were …]. I'd like to talk about what to do next.

A clinician will commonly follow up by taking a more detailed history (current symptoms across the four GAD-7 days-per-week response options, panic episodes, avoidance, physical anxiety, sleep, daily functioning), screening for differential diagnoses the GAD-2 does not separate among (panic disorder, social anxiety disorder, specific phobias, PTSD, OCD, adjustment disorders), assessing daily impact (work, relationships, basic self-care), and ruling out medical or medication contributors (thyroid function, caffeine, stimulants, decongestants, certain antidepressants in the first few weeks). Practice guidelines (American Psychiatric Association, NICE) commonly recommend cognitive-behavioural therapy as a first-line treatment for moderate or severe generalized anxiety disorder, with selective serotonin reuptake inhibitors (SSRIs) as an evidence-based pharmacological option; the combination of cognitive-behavioural therapy plus SSRI outperforms either alone in head-to-head trials at higher severity. The clinician will walk you through what is appropriate for your specific picture. You can print this page or save it as PDF using your browser's print menu — the result, score, and items all carry through.

If you're reading this with someone who took the test

If you are a partner, parent, sibling, close friend, or housemate reading this result alongside the person who took the test, this section is addressed to you. A positive GAD-2 is a triage signal, not a verdict — it is a small piece of information that the longer GAD-7 (or a clinical conversation) is the right next step. The most useful thing you can do at this stage is help them get there, not interpret the 0–6 number as if it told you the severity of what they are carrying. The 2-item ultra-brief screen was never designed to support that kind of interpretation; that is what the GAD-7 is for, and the natural next step from a positive GAD-2 is usually the full 7-item version (two minutes) or a clinical appointment.

Three things that consistently help: showing up steady and present without trying to solve the anxiety; offering practical help with tasks that anxiety has made harder (driving them to an appointment, sitting with them through a phone call they cannot bring themselves to make, handling a logistics pile that has grown too daunting); and asking calmly what kind of support feels most useful right now. Anxiety does not respond to logical rebuttals — pointing out that the feared outcome is unlikely, or asking them to look at the evidence, tends to offer only a few seconds of relief before the worry reconstitutes itself and can make the person feel more alone in the experience, not less. The goal is not to argue them into a calmer state; it is to be a steady, non-reactive presence while they move through it.

Three things that tend not to help: telling them to relax, calm down, or take a deep breath (this signals that the anxiety is the problem rather than the situation that is producing it); drawing comparisons to your own stress level or to someone else who managed (these land as minimizing even when meant to be reassuring); and offering have-you-tried suggestions for apps, supplements, breathing techniques, or specific medications that the person has almost certainly already considered or tried. Most people who screen positive on an ultra-brief anxiety tool have spent considerable time thinking about their own anxiety; the help that lands tends to be smaller, more concrete, and more present than the help that tries to fix the whole picture.

One situation calls for specific preparation: if they have panic episodes in front of you, the most useful response is to stay nearby, keep your voice low and even, and not coach their breathing unless they ask. Panic peaks at roughly ten minutes and self-resolves. Your visible calm is more useful than your instructions. If anxiety has reached a point where it is meaningfully compressing their daily life — avoided appointments, missed work, dropped commitments, withdrawal from people or activities they would normally engage — helping them schedule and keep the first clinical appointment is one of the most concrete, high-leverage things you can do. Getting to the room is often the hardest single step. If they mention thoughts of suicide or self-harm — including passive thoughts of not wanting to be here, wishing they could just stop, or feeling that others would be better off without them — that is information to take seriously rather than redirect away from. Suggesting they call or text 988 (US Suicide and Crisis Lifeline, free and confidential) while you sit with them is a concrete next step. If they feel unsafe or you feel they may not stay safe, an emergency department visit is appropriate. Asking about suicidal thoughts does not put the idea in someone's head; it makes it possible for them to talk about something they may have been carrying alone.

Other screens you might also take

The GAD-2 is an ultra-brief triage step; the natural confirmatory next step is the full 7-item GAD-7, which is pinned at the top of the list below for that reason. Several patterns commonly co-occur with a positive GAD-2 and call for different responses than generalized anxiety alone. The cards below give you the most useful follow-up paths.